NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.41
-2.42 (-7.39%)
At close: Mar 3, 2026, 4:00 PM EST
31.48
+1.07 (3.54%)
Pre-market: Mar 4, 2026, 6:31 AM EST

NAMS Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,4964,0132,777921889-
Market Cap Growth
64.01%44.50%201.49%3.62%--
Enterprise Value
2,7673,3771,944580.8418.740
Last Close Price
30.4135.0825.7011.1710.909.75
PE Ratio
--20.40-10.04-5.20-9.16-
PS Ratio
155.35178.3460.9565.388.66-
PB Ratio
5.095.873.672.471.71-
P/TBV Ratio
5.276.083.202.460.404.07
P/FCF Ratio
--27.11-17.44-6.5285.12-
P/OCF Ratio
--27.16-17.52-6.5283.36-
EV/Sales Ratio
122.97150.0742.6641.224.08-
EV/EBITDA Ratio
--14.98-11.03-3.17-118.02-
EV/EBIT Ratio
--14.96-11.02-3.17-117.72-
EV/FCF Ratio
--22.81-12.21-4.1140.09-
Debt / Equity Ratio
0.000.000.000.000.000.00
Debt / EBITDA Ratio
0.000.000.000-0.040.00
Debt / FCF Ratio
0.000.000.0000.01-0.01
Net Debt / Equity Ratio
-0.93-0.93-1.10-0.91-0.90-1.06
Net Debt / EBITDA Ratio
2.822.824.731.86132.541.78
Net Debt / FCF Ratio
4.304.305.242.41-45.032.10
Asset Turnover
0.030.030.070.030.320
Quick Ratio
7.427.427.856.3812.375.37
Current Ratio
7.887.888.086.5012.645.96
Return on Equity (ROE)
-28.29%-28.29%-42.73%-39.62%-7.85%-124.45%
Return on Assets (ROA)
-27.63%-27.63%-27.12%-36.39%-1.11%-85.65%
Return on Invested Capital (ROIC)
-373.87%-373.87%-467.29%-255.31%-9.31%2050.55%
Return on Capital Employed (ROCE)
-31.32%-31.32%-30.93%-40.02%-1.21%-129.52%
Earnings Yield
-5.83%-4.90%-9.96%-19.25%-10.92%0.00%
FCF Yield
-4.23%-3.69%-5.73%-15.33%1.17%-
Buyback Yield / Dilution
-0.74%-0.74%-23.75%-0.97%-44.00%-
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q